Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

NCT06255379 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Metastasis Colorectal Cancer
Colon Cancer
Rectal Cancer

Interventions

DRUG: Fuquinitinib+Tegafur Gimeracil Oteracil

Sponsor

Guangzhou University of Traditional Chinese Medicine